Author name: Dr. Amelia R. Tharn, PharmD, PhD

Dr. Amelia R. Thornton is a dual-trained clinical pharmacologist and pharmaceutical researcher with over 14 years of experience in drug safety evaluation, pharmacokinetics, and active ingredient optimization. She holds a PharmD and a PhD in Pharmaceutical Sciences, with her doctoral research focusing on metabolic drug–drug interactions in commonly prescribed medications. At Active Ingredient Hub, Dr. Thornton translates complex pharmaceutical data into practical, evidence-based insights. Her writing often bridges regulatory science with everyday pharmacy practice—helping readers understand how excipients, bioavailability, and formulation choices directly affect patient outcomes. Beyond academia, Amelia has worked alongside hospital pharmacists, participated in post-market surveillance studies, and contributed to medication safety guidelines used in clinical settings. Her ability to combine regulatory knowledge with real-world application makes her content especially valuable to pharmacists, healthcare professionals, and scientifically curious readers. When she’s not reviewing clinical trial data, Amelia enjoys early-morning cycling, watercolor painting, and experimenting with plant-based cooking. She’s also an advocate for mental health awareness among healthcare professionals and believes science communication should be as compassionate as it is accurate.

Pharmacy

IS THE ACTIVE INGREDIENT IN BENADRYL DANGEROUS? SIDE EFFECTS YOU NEED TO KNOW

Dr. Amelia R. Tharn, PharmD, PhD

When most people reach for that familiar pink box in their medicine cabinet, they see a reliable remedy for itchy eyes or a stubborn bout of hay fever. But as a clinical pharmacologist, I see diphenhydramine, a potent first-generation antihistamine with a complex molecular profile that demands far more respect than its over-the-counter status might […]